Mark S Freedman
19PUBLICATIONS
108CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (19)
Sort by Publication Date:
|Jan 30, 2026
Demographic and Clinical Characteristics of Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder in Canadian Adults.Amirah I Momen, Mark S Freedman, Giulia Fadda
|Dec 15, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.Rebecca I Spain, M Mateo Paz Soldán, Mark S Freedman
|Oct 03, 2025
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis.Laura Ghezzi, Peter Kosa, Mark Greenwood
|Jul 17, 2025
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression.Marianna Cortese, Xiaojing Peng, Gilles Edan
|Jun 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning
|Jun 09, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations.Mark S Freedman, Fraser Clift, Virginia Devonshire
Pageof 4
Frequent Collaborators
3 joint publications
Sarah A Morrow
3 joint publications
Tjalf Ziemssen
2 joint publications
Courtney S Casserly
2 joint publications
Ahmed Abdelhak
2 joint publications
Anthony Traboulsee
2 joint publications
Hans-Peter Hartung
2 joint publications
James B Lewin
2 joint publications
Tammy Jiang
1 joint publications
M Hii
1 joint publications
A Riddehough
